-
Mashup Score: 2CAR T-Cell Therapy ALLO-316 Produces Responses in Rel/Ref ccRCC - Renal and Urology News - 10 day(s) ago
Phase 1 results support further evaluation of ALLO-316 in patients with CD70-positive clear cell renal cell carcinoma, according to researchers.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
According to AstraZeneca, the FDA is expected to make a decision on the application during the second quarter of 2025. The FDA has granted Priority Review to durvalumab for the treatment of adults with muscle-invasive bladder cancer.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
The FDA has granted Priority Review to durvalumab for the treatment of adults with muscle-invasive bladder cancer. https://t.co/5p5fTeh517
-
-
Mashup Score: 0Robotic Partial Cystectomy Safe After Neoadjuvant Chemotherapy for MIBC - Renal and Urology News - 11 day(s) ago
Small retrospective study showed that the procedure achieved negative surgical margins in all cases, with no patients requiring salvage cystectomy.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Robot-assisted partial cystectomy following neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC) is a safe procedure. https://t.co/QLkFiwop0g #blcsm #SUO24
-
-
Mashup Score: 0
Among health care personnel, influenza vaccination has not returned to 2019 levels, and COVID-19 vaccinations have been decreasing.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Among health care personnel, influenza vaccination has not returned to 2019 levels, and COVID-19 vaccinations have been decreasing. https://t.co/AL8reEAxwi
-
-
Mashup Score: 0Comparable Results Seen for HoLEP With, Without Preservation of Urethral Mucosa in BPH - 11 day(s) ago
HoLEP with and without preservation of the urethral mucosa from bladder neck to the tip of the prostate yielded similar efficacy, safety
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
HoLEP with and without preservation of the urethral mucosa from bladder neck to the tip of the prostate yielded similar efficacy, safety. https://t.co/fIBlKgm1cu
-
-
Mashup Score: 0Mortality Risks Comparable for High-Grade Localized, Locally Advanced RCC - Renal and Urology News - 11 day(s) ago
Investigators compared survival outcomes of T1-T2 high-grade RCC and T3 any grade RCC.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
The presence of high-grade disease is a marker for adverse oncologic outcomes, particularly early mortality, in patients with T1 and T2 #kidney cancer. https://t.co/PcRkXoGTzO #kcsm #SUO24
-
-
Mashup Score: 0
Strongest influence seen between 55 and 64 years in men and between 65 and 74 years in women
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Targeting cardiovascular risk and obesity a decade earlier in males than females may be imperative. https://t.co/npRSEaXeaY
-
-
Mashup Score: 0
More than two-thirds of patients with negative chest X-ray results prescribed antibiotics
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
More than two-thirds of patients with negative chest X-ray results are prescribed antibiotics. https://t.co/lvsI3IRAF5
-
-
Mashup Score: 1Complete Functional Recovery After Radical Nephrectomy Linked to Better Survival - Renal and Urology News - 12 day(s) ago
Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Investigators identified the prevalence, predictors, and survival outcomes of complete functional recovery after radical nephrectomy for #kidney cancer. https://t.co/aNAxiPYpYi #kcsm #SUO24
-
-
Mashup Score: 0
At the 2024 LUGPA annual meeting, Gautam Jayram, MD, reviewed important developments therapeutics and diagnosis and staging.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Therapeutic options to treat intermediate-risk and BCG-unresponsive bladder cancer, such as medications and ablative therapies, are expanding, and novel PET tracers enable improved diagnosis and staging of clear cell renal cell carcinoma. https://t.co/hNwXyS47NB #kcsm
-
ALLO-316, a CD70-targeting chimeric antigen receptor (CAR) T-cell therapy, has demonstrated activity in patients with relapsed or refractory advanced clear cell renal cell carcinoma. https://t.co/q9dgd5BacB